Energy Transfer LP heads into its August 4 earnings date with the stock at a 12-month high and an analyst community that spent the past week adding conviction — the most interesting question now is whether the fundamental picture can justify the re-rating.
The clearest signal this week is on the Street. TD Cowen's Jason Gabelman raised his price target to $24 on July 16, maintaining a Buy rating — the freshest move in an otherwise uniformly constructive analyst pack. That follows a wave of May upgrades from JPMorgan, Barclays, Scotiabank, Citigroup, and Stifel, all of which lifted targets after Q1 results. The consensus mean sits at $23.81, roughly 17% above the current price of $20.32. Valuation has drifted modestly higher over the past 30 days — the P/E has expanded to 13.3x and EV/EBITDA to 8.4x — but both multiples still look undemanding for a midstream operator of this scale. The forward earnings yield ranks in the 75th percentile for 12-month EPS growth expectations, and the dividend score is a standout at 87th percentile, reflecting ET's relevance to income-oriented investors.
The lending market tells a story of almost total disinterest from short sellers. Borrow availability is extraordinarily loose — over 9,000% of short interest is available to borrow, meaning lenders have far more shares sitting idle than bears want to use. Short interest is less than 1% of the free float, and has risen only modestly over the past month. Cost to borrow nearly doubled on a week-over-week basis, but the absolute level at 0.25% remains trivially low — the sort of move that reflects noise rather than a structural shift in borrowing demand. The ORTEX short score of 30.9 has ticked up day-by-day across the past two weeks, but from an already-low base. Nothing in the lending market suggests shorts are building a meaningful case against the stock.
Options sentiment is similarly relaxed. The put/call ratio of 0.18 is barely above its 20-day average and sits near the lower end of the past year's range — call activity continues to dominate, consistent with a market that views $20 as a launchpad rather than a ceiling. Midstream peers broadly moved in the same direction this week: TRGP added 3.5%, OKE gained 4.0%, and EOG climbed 4.3%. WMB was the outlier, slipping 2.2%.
The more interesting tension sits beneath the bullish surface. The bear case is specific and concrete: free cash flow turned negative in Q2 as a $6.4 million capex surge overwhelmed revenue gains, the project backlog contracted 19% year-over-year, and forward gross margin estimates have been trimmed. Founder and Executive Chairman Kelcy Warren — the partnership's largest holder at 8.9% — bought 4 million units across August and November 2025 at prices between $17 and $17.36, acquisitions that look prescient now with the stock 20% higher. C-suite sells in December 2025 at $16.60, while less directionally significant given their smaller scale, complete a picture of insiders active at lower prices. The institutional base remains stable, with ALPS Advisors, Tortoise Capital, and Kayne Anderson all recently adding units.
With earnings on August 4, the next print is less about whether ET's pipeline volumes are growing and more about whether management can demonstrate that Q2's free cash flow dip was a temporary capex trough rather than a structural deterioration in the partnership's distribution coverage.
See the live data behind this article on ORTEX.
Open ET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
